Adding pirfenidone to mycophenolate mofetil shows no significant improvement in lung function compared with mycophenolate ...

Registry analysis suggests endoscopic lung volume reduction yields similar physiologic gains across sexes, but women report ...

Viral flu cases are rising across north India this winter. Firstpost brings out experts’ explain how air pollution, cold ...

Chronological age is a primary method for assessing healthcare managers’ decisions regarding how to treat and care for ...

The anti-interleukin agent romilkimab showed significant benefits on skin fibrosis among patients with systemic sclerosis in a phase II trial, researchers reported. At week 24, the least squares mean ...

Apollo Hospitals in Chennai, capital of India's southern state of Tamil Nadu, has deployed an AI-powered scan system to ...

Interstitial lung disease is the most common cause of death in patients with systemic sclerosis. Cyclophosphamide, with or without steroids, is thought to modify the course of lung disease in these ...

The Food and Drug Administration (FDA) has expanded the approval of Jascayd ® (nerandomilast), an oral phosphodiesterase 4 inhibitor, to include treatment of progressive pulmonary fibrosis (PPF) in ...

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

Normalize and accept the desire to procrastinate without feeling the need to act on it. Just because you don’t want to work at this moment in time, does not mean that you are a procrastinator.

Paul Wines helped to kick in the door of the warehouse and heard a sound like a freight train crashing through town. A blaze fueled by leather goods and ...

Discover the greatest AI innovations and new technologies of 2025 from autonomous agents and multimodal models to robotics ...